Actively Recruiting
Characterization of Arrhythmia-induced Cardiomyopathy
Led by University Hospital, Basel, Switzerland · Updated on 2025-03-04
2700
Participants Needed
1
Research Sites
290 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of the this observational study is to gather clinically available data on patients presenting with a suspicion for arrhythmia-induced cardiomyopathy (AiCM) at the University Hospital Basel.
CONDITIONS
Official Title
Characterization of Arrhythmia-induced Cardiomyopathy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnostic or suspicion of AiCM as presence of specified keyword in patient's file or as screened by colleagues of the internal medicine or cardiology clinics
- Signed study consent
- Patients with a reduced left-ventricular ejection fraction (LVEF 50%) or a reduction of 15% in the ejection fraction (EF) between two echocardiographies and a concomitant diagnosis of any arrhythmia likely to lead to AiCM within one year before or after diagnosis of the reduced LVEF from 2010-2021
You will not qualify if you...
- Patient's active refusal of the general consent of the University Hospital Basel
- Age <18 years old
- Temporary exclusion criteria: Acute health condition such as myocardial infarction, patients presenting with a major trauma, a sepsis, patients shortly after cardiac surgery, and patients in shock (>100 bpm, <90 systolic BP, evidence of organ dysfunction)
- Life expectancy <1 year (palliative, terminal cancer)
- Acute event clearly leading to an acutely reduced LVEF (massive type I myocardial infarction, cardiogenic shock from a coronary or myocardial etiology, septic shock leading to toxic myopathy, hypovolemic shock with reduced EF, cardiac arrest and/or need for resuscitation)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Hospital Basel, Department of Cardiology
Basel, Switzerland, 4031
Actively Recruiting
Research Team
P
Patrick Badertscher, MD
CONTACT
J
Jeanne du Fay de Lavallaz, MD-PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here